Health topic
Clinical Research
Why representation in research matters, and how to find and join trials safely.
The number
<5%
Of clinical trial participants are Black
Why it matters
When research does not include us, treatments are not proven for us. Participation — with informed protections — changes that.
- Ask if a trial is right for you
- Know your rights as a participant
- Use trial finders from trusted institutions
- Ask HBCU researchers about local studies
Articles
View all newsroom
Latest · Clinical Trials
Expanding Global Health Equity Through Inclusive Clinical Trial Participation
Increasing diversity in medical research and strengthening the pipeline of Black clinical investigators are vital steps toward global health equity and better outcomes for underrepresented populations.
September 29, 2026 · Source: Asia Society
Clinical Trials
Simple $25 Incentive Nearly Doubles Black and Hispanic Clinical Trial Participation, Study Finds
Research from Penn LDI shows a modest stipend significantly boosts minority participation in medical studies, highlighting a practical strategy to address long-standing health disparities.
September 29, 2026 · Source: Penn LDI
Clinical Trials
Clinical Trial Highlights How 'White Cast' Impedes Sunscreen Adoption Among Black Consumers
A clinical trial reveals how the chalky residue left by traditional sunscreens deters Black consumers from daily sun protection, underlining the need for better formulations and inclusive dermatological care.
September 29, 2026 · Source: Black Doctor
Clinical Trials
Strategies to Expand Black and Hispanic Representation in Pediatric Clinical Trials
A new study outlines critical strategies to remove structural barriers and build trust among families of color in pediatric medical research.
September 29, 2026 · Source: Medical Xpress
Clinical Trials
Study Warns Black-Market Retatrutide Lacks Efficacy and Safety of Clinical Trial Formulations
A new report warns that unauthorized, black-market versions of the investigational drug retatrutide fall short of the efficacy demonstrated in legitimate clinical research, posing grave risks to vulnerable patient populations.
September 29, 2026 · Source: Partnership for Safe Medicines